Single Cell Multiomics Market Forecast Assessing Growth Potential And Industry Direction

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Single Cell Multiomics Market During 2026–2030?

The single cell multiomics market has experienced substantial expansion in recent times. It is projected to increase from $4.85 billion in 2025 to $5.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 22.1%. This historical growth was largely propelled by progress in single-cell sequencing technologies, the broadening of cancer research initiatives, increasing investments in life sciences research, enhanced access to high-throughput analysis tools, and expanding academic research funding.

The single cell multiomics market size is projected to undergo significant expansion over the next few years. It is expected to achieve a value of $13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 21.7%. This growth during the forecast period can be attributed to the escalating demand for precision medicine applications, wider integration into clinical research workflows, the proliferation of multiomics data integration platforms, increasing investments in pharmaceutical research, and sustained advancements in analytical sensitivity. Significant trends for this period involve the rising adoption of integrated multiomics platforms, a heightened requirement for high-resolution single-cell analysis, the increasing utilization of AI-driven data interpretation tools, the development of multi-modal cellular profiling techniques, and a stronger emphasis on insights into cellular heterogeneity.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20630&type=smp

Which Significant Factors Are Encouraging Growth In The Single Cell Multiomics Market?

The growing need for precision medicine is anticipated to drive the expansion of the single cell multiomics market in the future. Precision medicine denotes a medical methodology that customizes treatments and healthcare plans based on each patient’s unique attributes. This rise in precision medicine stems from progress in genomic research, improved data analysis functionalities, and a greater appreciation for the benefits of personalized healthcare. Single-cell multiomics offers comprehensive insights into how cells differ and their molecular workings, which facilitates the creation of highly customized treatments designed for specific patients’ distinct cellular makeups. For example, in May 2025, the U.S.-based professional organization, Personalized Medicine Coalition (PMC), reported that in 2023, the U.S. Food and Drug Administration (FDA) sanctioned 18 new personalized medicines, accounting for approximately 38% of all recently approved therapeutic molecular entities. Consequently, the rising requirement for precision medicine is fueling the expansion of the single cell multiomics market.

What Segment Categories Are Evaluated In The Single Cell Multiomics Market Study?

The single cell multiomics market covered in this report is segmented –

1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics

2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis

3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research

4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies

Subsegments:

1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms

2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms

3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools

4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools

What Trends Are Driving Changes In The Single Cell Multiomics Market?

Major companies within the silver wound dressing market are concentrating on developing advanced products, such as antimicrobial wound dressings, to address the increasing demand for more effective and sustainable wound care solutions. Antimicrobial wound dressings are sophisticated wound care products infused with antimicrobial agents to prevent or minimize infections. For instance, in November 2024, Imbed Biosciences, a US-based biotechnology company, introduced Microlyte Ag/Lidocaine, an antimicrobial wound dressing that integrates lidocaine, which obtained Food and Drug Administration (FDA) 510(k) clearance for managing painful skin wounds. This innovative dressing utilizes Imbed’s patented synthetic matrix to deliver ionic and metallic silver alongside lidocaine, providing antimicrobial protection and local anesthetic effects by releasing 40 mg of lidocaine hydrochloride USP per 100 cm² of the wound area. It is indicated for various partial- and full-thickness wounds, including venous stasis ulcers, pressure sores, ischemic ulcers, burns, surgical wounds, and abrasions, potentially reducing infection risk and pain while lowering reliance on systemic antibiotics and opioids.

Who Are The Key Market Participants In The Single Cell Multiomics Market?

Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd, 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd, Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS

Access The Complete Single Cell Multiomics Market Report:

https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report

Which Geographic Region Represents The Largest Single Cell Multiomics Market Share?

North America was the largest region in the single cell multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single cell multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Single Cell Multiomics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20630&type=smp

Browse Through More Reports Similar to the Global Single Cell Multiomics Market 2026, By The Business Research Company

Flow Cytometry In Oncology And Immunology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Stem Cell Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Cellular Telephone Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795